Bausch Health Companies BHC Solta Medical — SG&A

Other segment segments

Similar metrics at other companies

NOVTMedical Solutions — Selling General And Administrative Expense

$16.31M+10.7%

MDTMedical Surgical — Selling, general, and administrative expense

$650M+9.6%

CXTSAT — SG&A

$53.1M+33.4%

ABTMedical Devices — Selling, general, and administrative

$1.39B+7.8%

BDXMedical — Selling and administrative expense

$328M+27.3%

PODDSG&A

$317.2M+21.7%

Questions, answered.

What is Bausch Health Companies's solta medical — SG&A?

Bausch Health Companies (BHC) reported solta medical — SG&A of $35M in Q1 2026.

How has Bausch Health Companies's solta medical — SG&A changed year-over-year?

Bausch Health Companies's solta medical — SG&A increased by 25.0% year-over-year, from $28M to $35M.

What is the long-term trend for Bausch Health Companies's solta medical — SG&A?

Over 3 years (2022 to 2025), Bausch Health Companies's solta medical — SG&A has grown at a 17.9% compound annual growth rate (CAGR), from $80M to $131M.

What does solta medical — SG&A mean?

Includes all non-production operating expenses incurred to support the Solta Medical segment, such as marketing, sales force compensation, and administrative overhead. Monitoring this helps evaluate the operational efficiency and cost structure required to sustain segment revenue.